Ausgabe 1/2020
Inhalt (26 Artikel)
Uterine cancer in breast cancer survivors: a systematic review
Akemi T. Wijayabahu, Kathleen M. Egan, Lusine Yaghjyan
Cyclin-dependent kinase 4 and 6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer: a meta-analysis of randomized clinical trials
Jing Li, Fangmeng Fu, Liuwen Yu, Meng Huang, Yuxiang Lin, Qian Mei, Jinxing Lv, Chuan Wang
Healthcare system distrust and the breast cancer continuum of care
Morgane C. Mouslim, Renee M. Johnson, Lorraine T. Dean
Histone methyltransferases regulate the transcriptional expression of ERα and the proliferation of tamoxifen-resistant breast cancer cells
Seung-Su Kim, Min-Ho Lee, Mi-Ock Lee
Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast disease
Sabina Adhikary, Tanya L. Hoskin, Melody L. Stallings-Mann, Muhammad Arshad, Marlene H. Frost, Stacey J. Winham, Alvaro Peña, Delphine J. Lee, Linda M. Murphy, Michele Rakoff, Lori A. Denison, Keith L. Knutson, Derek C. Radisky, Daniel W. Visscher, Amy C. Degnim
Symptom cluster of pain, fatigue, and psychological distress in breast cancer survivors: prevalence and characteristics
Ellen Bjerkeset, Kari Röhrl, Inger Schou-Bredal
MRPS23 amplification and gene expression in breast cancer; association with proliferation and the non-basal subtypes
Elise Klæstad, Signe Opdahl, Monica Jernberg Engstrøm, Borgny Ytterhus, Elisabeth Wik, Anna Mary Bofin, Marit Valla
Squamous cell carcinoma of the breast, are there two entities with distinct prognosis? A series of 39 patients
F. Pirot, D. Chaltiel, A. Ben Lakhdar, M. C. Mathieu, F. Rimareix, A. Conversano
Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling
Ayako Kanai, Keely May McNamara, Erina Iwabuchi, Yasuhiro Miki, Yoshiaki Onodera, Fouzia Guestini, Freeha Khalid, Yasuaki Sagara, Yasuyo Ohi, Yoshiaki Rai, Rin Yamaguchi, Maki Tanaka, Minoru Miyashita, Takanori Ishida, Hironobu Sasano
Double reading of diffusion-weighted magnetic resonance imaging for breast cancer detection
Anna Rotili, Rubina Manuela Trimboli, Silvia Penco, Filippo Pesapane, Priyan Tantrige, Enrico Cassano, Francesco Sardanelli
Effectiveness of adjuvant supportive-expressive group therapy for breast cancer
Zeng Jie Ye, Zhang Zhang, Xiao Ying Zhang, Ying Tang, Jian Liang, Zhe Sun, Mu Zi Liang, Yuan Liang Yu
A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer
Norikazu Masuda, Shoichiro Ohtani, Toshimi Takano, Kenichi Inoue, Eiji Suzuki, Rikiya Nakamura, Hiroko Bando, Yoshinori Ito, Kazushige Ishida, Takashi Yamanaka, Katsumasa Kuroi, Hiroyuki Yasojima, Hiroi Kasai, Tsuyoshi Takasuka, Takaki Sakurai, Tatsuki R. Kataoka, Satoshi Morita, Shinji Ohno, Masakazu Toi
Systemic therapy following craniotomy in patients with a solitary breast cancer brain metastasis
Alexander F. C. Hulsbergen, Logan D. Cho, Marco Mammi, Nayan Lamba, Timothy R. Smith, Priscilla K. Brastianos, Marike L. D. Broekman, Nancy U. Lin
Red clover and lifestyle changes to contrast menopausal symptoms in premenopausal patients with hormone-sensitive breast cancer receiving tamoxifen
Cristina Ferraris, Barbara Ballestra, Chiara Listorti, Vera Cappelletti, Carolina Reduzzi, Gianfranco P. Scaperrotta, Iolanda Pulice, Eleonora G. A. Ferrari, Secondo Folli, Luigi Mariani, Gabriele Martelli
The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer
Jana de Boniface, Johan Ahlgren, Yvette Andersson, Leif Bergkvist, Jan Frisell, Dan Lundstedt, Roger Olofsson Bagge, Lisa Rydén, Malin Sund, Peer Christiansen, Tove Filtenborg Tvedskov, Birgitte Vrou Offersen, Toralf Reimer, Thorsten Kühn, Michalis Kontos, Oreste Gentilini, Roland Reitsamer
Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients
Mara Tynan, Beth N. Peshkin, Claudine Isaacs, Shawna Willey, Heiddis B. Valdimarsdottir, Rachel Nusbaum, Gillian Hooker, Suzanne C. O’Neill, Lina Jandorf, Scott P. Kelly, Jessica Heinzmann, Sarah Kelleher, Elizabeth Poggi, Marc D. Schwartz
Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study
Song Yao, Cecile A. Laurent, Janise M. Roh, Joan Lo, Li Tang, Theresa Hahn, Christine B. Ambrosone, Lawrence H. Kushi, Marilyn L. Kwan
Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy
Audree B. Tadros, Tracy-Ann Moo, Michelle Stempel, Emily C. Zabor, Atif J. Khan, Monica Morrow
Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients
Oluwadamilola M. Fayanju, Yi Ren, Rachel A. Greenup, Jennifer K. Plichta, Laura H. Rosenberger, Jeremy Force, Gita Suneja, Gayathri R. Devi, Tari A. King, Faina Nakhlis, Terry Hyslop, E. Shelley Hwang
Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence
Catherine Lee, Devon K. Check, Leslie Manace Brenman, Lawrence H. Kushi, Mara M. Epstein, Christine Neslund-Dudas, Pamala A. Pawloski, Ninah Achacoso, Cecile Laurent, Louis Fehrenbacher, Laurel A. Habel
Breast cancer tumor histopathology, stage at presentation, and treatment in the extremes of age
Jennifer K. Plichta, Samantha M. Thomas, Rebecca Vernon, Oluwadamilola M. Fayanju, Laura H. Rosenberger, Terry Hyslop, E. Shelley Hwang, Rachel A. Greenup
The novel TP53 3′-end methylation pattern associated with its expression would be a potential biomarker for breast cancer detection
Feng Zeng, Jianfu Heng, Xinwu Guo, Yue Wang, Wenhan Wu, Lili Tang, Min Chen, Shouman Wang, Hongyu Deng, Jun Wang
Patient-reported outcome after oncoplastic breast surgery compared with conventional breast-conserving surgery in breast cancer
Michael Rose, Henry Svensson, Jürgen Handler, Ute Hoyer, Anita Ringberg, Jonas Manjer
Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer
Ximena García, Andrés Elía, Lucrecia Galizzi, María May, Eunice Spengler, Paula Martínez Vázquez, Javier Burruchaga, Hugo Gass, Claudia Lanari, Caroline A. Lamb
RE: Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort
Gianluca Lopez, Nicola Fusco
Nationwide prevalence and trends of acute cardiovascular and cerebrovascular events among adult breast cancer survivors with a history of radiation therapy
Snehal Bansod, Rupak Desai